Clinical trial
Alzheimer's Disease: Potential Benefit of Isoflavones
NCT00205179 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00205179 |
|---|---|
| Title | Alzheimer's Disease: Potential Benefit of Isoflavones |
| Official title | Alzheimer's Disease: Potential Benefit of Isoflavones |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute on Aging (NIA) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Novasoy, Placebo |
| Enrollment | 72 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 22, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: